Hyderabad, Jun 30 (UNI) COVAXIN, India's indigenous COVID-19 vaccine , has now received Emergency Use Authorizations (EUA) in 16 countries including, Brazil, India, Philippines, Iran and Mexico, vaccine maker Bharat Biotech said here on Wednesday.
With EUA’s in process in 50 countries worldwide, discussions are going on with WHO to obtain Emergency Use Listing for COVAXIN, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV).
The product has been exported to several countries, with additional requests for supplies being received, Hyderabad based Bharat Biotech said in a statement.